Delcath Systems (DCTH) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $14.08, -4.93% vs the prior close of $14.81.
- Volume 383.85K shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
DCTH slides 4.9% to $14.08, a 1-month low. Closed at $14.08, -4.93% vs the prior close of $14.81. Day range $14.00–$14.83, opened at $14.81.
DCTH daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — DCTH slides 4.9% to $14.08, a 1-month low
- Closed at $14.08, -4.93% vs the prior close of $14.81. Day range $14.00–$14.83, opened at $14.81.
- Volume was 383.85K shares, 0.8x its 50-day average of 496.22K.
- Price is -12.6% vs its 50-day average ($16.11) and +16.1% vs its 200-day average ($12.13).
- 52-week range $8.12–$17.42; today's close sits at 64% of that range, 19.2% below the 52-week high.
Oct 15, 2026 — DCTH rises 0.6% to $14.81
- Closed at $14.81, +0.61% vs the prior close of $14.72. Day range $14.62–$14.97, opened at $14.70.
- Volume was 214.90K shares, 0.4x its 50-day average of 500.57K — lighter than usual.
- Price is -8.2% vs its 50-day average ($16.13) and +22.3% vs its 200-day average ($12.11).
- 52-week range $8.12–$17.42; today's close sits at 72% of that range, 15.0% below the 52-week high.
Oct 14, 2026 — DCTH slides 3.9% to $14.72, a 1-month low
- Closed at $14.72, -3.92% vs the prior close of $15.32. Day range $14.69–$15.41, opened at $15.24.
- Volume was 232.00K shares, 0.5x its 50-day average of 504.76K — lighter than usual.
- Price is -8.5% vs its 50-day average ($16.09) and +21.8% vs its 200-day average ($12.08).
- 52-week range $8.12–$17.42; today's close sits at 71% of that range, 15.5% below the 52-week high.
Oct 13, 2026 — DCTH dips 2.2% to $15.32
- Closed at $15.32, -2.23% vs the prior close of $15.67. Day range $15.30–$15.77, opened at $15.57.
- Volume was 251.40K shares, 0.5x its 50-day average of 511.33K — lighter than usual.
- Price is -4.6% vs its 50-day average ($16.06) and +27.0% vs its 200-day average ($12.06).
- 52-week range $8.12–$17.42; today's close sits at 77% of that range, 12.1% below the 52-week high.
Oct 12, 2026 — DCTH rises 2.0% to $15.67
- Closed at $15.67, +2.02% vs the prior close of $15.36. Day range $15.30–$15.75, opened at $15.36.
- Volume was 207.50K shares, 0.4x its 50-day average of 514.62K — lighter than usual.
- Price is -2.1% vs its 50-day average ($16.01) and +30.2% vs its 200-day average ($12.04).
- 52-week range $8.12–$17.42; today's close sits at 81% of that range, 10.0% below the 52-week high.
Oct 9, 2026 — DCTH rises 2.1% to $15.36
- Closed at $15.36, +2.13% vs the prior close of $15.04. Day range $14.94–$15.40, opened at $15.07.
- Volume was 190.10K shares, 0.4x its 50-day average of 516.96K — lighter than usual.
- Price is -3.7% vs its 50-day average ($15.94) and +27.9% vs its 200-day average ($12.01).
- 52-week range $8.12–$17.42; today's close sits at 78% of that range, 11.8% below the 52-week high.
Oct 8, 2026 — DCTH dips 2.2% to $15.04, a 1-month low, 3 down days in a row
- Closed at $15.04, -2.21% vs the prior close of $15.38. Day range $14.52–$15.23, opened at $15.22.
- Volume was 416.30K shares, 0.8x its 50-day average of 515.43K.
- Price is -5.3% vs its 50-day average ($15.88) and +25.5% vs its 200-day average ($11.98).
- 52-week range $8.12–$17.42; today's close sits at 74% of that range, 13.7% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — DCTH ends flat (-0.2%) to $15.38
- Closed at $15.38, -0.19% vs the prior close of $15.41. Day range $15.27–$15.82, opened at $15.27.
- Volume was 263.10K shares, 0.5x its 50-day average of 521.90K — lighter than usual.
- Price is -2.7% vs its 50-day average ($15.81) and +28.6% vs its 200-day average ($11.96).
- 52-week range $8.12–$17.42; today's close sits at 78% of that range, 11.7% below the 52-week high.
Oct 6, 2026 — DCTH dips 2.9% to $15.41
- Closed at $15.41, -2.90% vs the prior close of $15.87. Day range $15.26–$15.91, opened at $15.87.
- Volume was 244.80K shares, 0.5x its 50-day average of 525.79K — lighter than usual.
- Price is -2.0% vs its 50-day average ($15.73) and +29.2% vs its 200-day average ($11.93).
- 52-week range $8.12–$17.42; today's close sits at 78% of that range, 11.5% below the 52-week high.
Oct 5, 2026 — DCTH jumps 4.9% to $15.87
- Closed at $15.87, +4.89% vs the prior close of $15.13. Day range $15.06–$15.97, opened at $15.18.
- Volume was 428.00K shares, 0.8x its 50-day average of 523.26K.
- Price is +1.3% vs its 50-day average ($15.66) and +33.3% vs its 200-day average ($11.90).
- 52-week range $8.12–$17.42; today's close sits at 83% of that range, 8.9% below the 52-week high.
Oct 2, 2026 — DCTH dips 1.8% to $15.13, a 1-month low
- Closed at $15.13, -1.82% vs the prior close of $15.41. Day range $15.06–$15.60, opened at $15.57.
- Volume was 436.60K shares, 0.8x its 50-day average of 520.00K.
- Price is -2.9% vs its 50-day average ($15.59) and +27.4% vs its 200-day average ($11.87).
- 52-week range $8.12–$17.42; today's close sits at 75% of that range, 13.1% below the 52-week high.
DCTH latest news & SEC filings
Every SEC filing by or about DCTH in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Rosalind Advisors, Inc. & Salamon Steven A J & Aharon Gil converted 3,627 shares on Oct 13, 2026; now holds 3,417,095
- Rosalind Advisors, Inc. & Salamon Steven A J & Aharon Gil reported an other transaction of 27,502 shares on Oct 13, 2026; now holds 3,389,593
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 14, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $29.13M (prior year $24.16M) (+20.6% vs Jun 30, 2025)
- Net income: $2.67M (prior year $2.70M) (-1.1% vs Jun 30, 2025)
- Diluted EPS: $0.07 (prior year $0.07) (+0.0% vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 28, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade DCTH
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Feb 26, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.10% (largest 4.9%).
- Liquidity: about 307.88K shares (≈$4.33M) trade per day on average.
- 52-week position: $14.08 vs a range of $8.12–$17.42 (64% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 16 open-market buys, 0 sales; latest: Sandra Pennell bought 5,533 shares on Mar 6, 2026.
- Latest filings: 8-K Aug 14, 2026; 10-Q Aug 6, 2026; 8-K Aug 6, 2026.
- Share count: 34.70M shares outstanding (Jul 31, 2026), -0.8% vs a year earlier.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
DCTH market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 14.81 | 14.83 | 14.00 | 14.08 | 383.85K |
| Oct 15, 2026 | 14.70 | 14.97 | 14.62 | 14.81 | 214.90K |
| Oct 14, 2026 | 15.24 | 15.41 | 14.69 | 14.72 | 232.00K |
| Oct 13, 2026 | 15.57 | 15.77 | 15.30 | 15.32 | 251.40K |
| Oct 12, 2026 | 15.36 | 15.75 | 15.30 | 15.67 | 207.50K |
| Oct 9, 2026 | 15.07 | 15.40 | 14.94 | 15.36 | 190.10K |
| Oct 8, 2026 | 15.22 | 15.23 | 14.52 | 15.04 | 416.30K |
| Oct 7, 2026 | 15.27 | 15.82 | 15.27 | 15.38 | 263.10K |
| Oct 6, 2026 | 15.87 | 15.91 | 15.26 | 15.41 | 244.80K |
| Oct 5, 2026 | 15.18 | 15.97 | 15.06 | 15.87 | 428.00K |
| Oct 2, 2026 | 15.57 | 15.60 | 15.06 | 15.13 | 436.60K |
| Oct 1, 2026 | 15.90 | 15.93 | 15.35 | 15.41 | 468.10K |
| Sep 30, 2026 | 15.88 | 16.02 | 15.70 | 15.97 | 300.70K |
| Sep 29, 2026 | 15.80 | 15.94 | 15.66 | 15.85 | 263.70K |
| Sep 28, 2026 | 15.75 | 15.84 | 15.38 | 15.81 | 304.20K |
| Sep 25, 2026 | 16.09 | 16.15 | 15.56 | 15.60 | 262.30K |
| Sep 24, 2026 | 15.91 | 16.10 | 15.52 | 16.08 | 276.50K |
| Sep 23, 2026 | 16.30 | 16.38 | 15.68 | 15.96 | 279.50K |
| Sep 22, 2026 | 16.20 | 16.43 | 16.05 | 16.40 | 368.60K |
| Sep 21, 2026 | 16.25 | 16.25 | 15.87 | 16.11 | 365.50K |
About Delcath Systems
Delcath Systems (DCTH) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in QUEENSBURY, NY. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 872912.
DCTH board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Gil Aharon | Director | May 14, 2026 |
| Elizabeth Czerepak | Director | May 14, 2026 |
| Gerard J Michel | CHIEF EXECUTIVE OFFICER | Mar 3, 2026 |
| Bridget A Martell | Director | May 14, 2026 |
| Steven A J Salamon | Director | May 14, 2026 |
| John Richard Sylvester | Director | May 14, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| David L. Hoffman | GEN'L COUNSEL, CCO & SECY | Feb 18, 2026 |
| Gerard J Michel | CHIEF EXECUTIVE OFFICER | Mar 3, 2026 |
| Kevin Muir | GM INTERVENTIONAL ONCOLOGY | Feb 18, 2026 |
| Sandra Pennell | Chief Financial Officer | Mar 6, 2026 |
| Martha S. Rook | CHIEF OPERATING OFFICER | Feb 18, 2026 |
| Vojo Vukovic | CHIEF MEDICAL OFFICER | Feb 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Mar 6, 2026 | Sandra Pennell | Buy | 5,533 | $9.04 |
| Mar 6, 2026 | Sandra Pennell | Buy | 5,533 | $9.04 |
| Mar 6, 2026 | Sandra Pennell | Buy | 5,533 | $9.04 |
| Mar 6, 2026 | Sandra Pennell | Buy | 5,533 | $9.04 |
| Mar 2, 2026 | Gerard J Michel | Buy | 11,200 | $8.96 |
| Mar 2, 2026 | Gerard J Michel | Buy | 11,200 | $8.96 |
| Mar 2, 2026 | Gerard J Michel | Buy | 11,200 | $8.96 |
| Mar 2, 2026 | Gerard J Michel | Buy | 11,200 | $8.96 |
| Nov 21, 2025 | John Richard Sylvester | Buy | 4,386 | $8.89 |
| Nov 21, 2025 | John Richard Sylvester | Buy | 4,386 | $8.89 |
| Nov 21, 2025 | John Richard Sylvester | Buy | 4,386 | $8.89 |
| Nov 21, 2025 | John Richard Sylvester | Buy | 4,386 | $8.89 |
| Nov 11, 2025 | Gerard J Michel | Buy | 11,500 | $8.53 |
| Nov 11, 2025 | Gerard J Michel | Buy | 11,500 | $8.53 |
| Nov 11, 2025 | Gerard J Michel | Buy | 11,500 | $8.53 |
DCTH financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $85.23M | $2.70M | 0.07 | $22.52M |
| Dec 31, 2024 | $37.20M | $-26.39M | -0.93 | $-18.68M |
| Dec 31, 2023 | $2.06M | $-47.68M | -2.94 | $-31.25M |
| Dec 31, 2022 | $2.72M | $-36.51M | -4.12 | $-24.95M |
| Dec 31, 2021 | $3.56M | $-25.65M | -3.59 | $-22.60M |
Latest balance sheet: total assets $137.02M, total liabilities $15.87M, cash $47.52M (as of Jun 30, 2026).
DCTH earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $15.47 |
| May 7, 2026 | 8-K Item 2.02 (results) | $11.24 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $9.00 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $10.29 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $9.08 |
| Oct 20, 2025 | 8-K Item 2.02 (results) | $11.42 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $10.64 |
| May 8, 2025 | 8-K Item 2.02 (results) | $14.35 |
| Mar 6, 2025 | 8-K Item 2.02 (results) | $13.22 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $12.79 |
| Nov 8, 2024 | 8-K Item 2.02 (results) | $11.06 |
| Oct 17, 2024 | 8-K Item 2.02 (results) | $10.23 |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on DCTH
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.